SHC2
Basic information
Region (hg38): 19:416589-461033
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 74 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 74 | 5 | 0 |
Variants in SHC2
This is a list of pathogenic ClinVar variants found in the SHC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-418938-C-T | not specified | Uncertain significance (Feb 05, 2025) | ||
19-418939-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
19-418954-G-A | not specified | Uncertain significance (May 09, 2023) | ||
19-418975-C-T | not specified | Uncertain significance (Dec 25, 2024) | ||
19-418978-C-A | not specified | Uncertain significance (Jul 21, 2021) | ||
19-418981-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
19-418989-T-C | not specified | Uncertain significance (Jan 26, 2023) | ||
19-418998-T-A | not specified | Uncertain significance (Dec 26, 2023) | ||
19-419020-G-T | not specified | Uncertain significance (Nov 17, 2022) | ||
19-419049-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
19-419053-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
19-422154-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
19-422160-C-G | not specified | Uncertain significance (Mar 31, 2024) | ||
19-422163-C-T | not specified | Uncertain significance (Jun 26, 2023) | ||
19-422187-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
19-422194-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
19-422222-T-C | not specified | Uncertain significance (Oct 25, 2023) | ||
19-422266-C-A | not specified | Uncertain significance (Jul 27, 2024) | ||
19-422268-T-C | not specified | Uncertain significance (Feb 05, 2025) | ||
19-422274-C-T | not specified | Uncertain significance (Dec 14, 2022) | ||
19-422282-C-T | not specified | Uncertain significance (Sep 01, 2024) | ||
19-422283-G-A | not specified | Uncertain significance (May 28, 2024) | ||
19-422285-C-A | not specified | Uncertain significance (Nov 11, 2024) | ||
19-422333-G-A | not specified | Uncertain significance (Feb 12, 2025) | ||
19-422339-G-T | not specified | Uncertain significance (Mar 18, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SHC2 | protein_coding | protein_coding | ENST00000264554 | 12 | 44414 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.13e-14 | 0.0315 | 124490 | 0 | 57 | 124547 | 0.000229 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.274 | 277 | 290 | 0.955 | 0.0000200 | 3653 |
Missense in Polyphen | 138 | 157.48 | 0.87632 | 1576 | ||
Synonymous | -0.203 | 138 | 135 | 1.02 | 0.0000110 | 1250 |
Loss of Function | 0.312 | 22 | 23.6 | 0.931 | 0.00000128 | 274 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000958 | 0.000928 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000513 | 0.000501 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000151 |
Middle Eastern | 0.000513 | 0.000501 |
South Asian | 0.000198 | 0.000196 |
Other | 0.000167 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Signaling adapter that couples activated growth factor receptors to signaling pathway in neurons. Involved in the signal transduction pathways of neurotrophin-activated Trk receptors in cortical neurons (By similarity). {ECO:0000250}.;
- Pathway
- Chronic myeloid leukemia - Homo sapiens (human);Gastric cancer - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Relaxin signaling pathway - Homo sapiens (human);VEGF signaling pathway - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Breast cancer - Homo sapiens (human);ErbB signaling pathway - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Glioma - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Prolactin signaling pathway - Homo sapiens (human);Alcoholism - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);EGFR Inhibitor Pathway, Pharmacodynamics;EGF-Core;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Focal Adhesion;VEGFA-VEGFR2 Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Chemokine signaling pathway;Ras Signaling;Insulin Signaling;ErbB Signaling Pathway;Signal Transduction;VEGFA-VEGFR2 Pathway;HGF;IGF signaling;insulin Mam;IL-5 signaling;Signalling to RAS;Signalling to ERKs;Signaling by NTRK1 (TRKA);Integrin;Signaling by NTRKs;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;PDGF;NGF;Signaling by VEGF;Signaling by Receptor Tyrosine Kinases;EGF;Neurotrophic factor-mediated Trk receptor signaling;VEGFR1 specific signals;insulin
(Consensus)
Recessive Scores
- pRec
- 0.245
Haploinsufficiency Scores
- pHI
- 0.0853
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.970
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Shc2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;activation of MAPK activity;Ras protein signal transduction;vascular endothelial growth factor receptor signaling pathway
- Cellular component
- cellular_component;cytosol;plasma membrane
- Molecular function
- Ras guanyl-nucleotide exchange factor activity;protein binding;receptor tyrosine kinase binding